BioPharma Pharma Research
New cell population identified in Alzheimer's Disease allows better targeting of macrophage populations in treatment of neurodegeneration
An Immunity research study has found that the previously identified disease associated microglia (DAM) population detected in murine Alzheimer’s dise...
October 11, 2022 | News
Cytiva strengthens cell line development with CEVEC acquisition
Viral vector manufacturing and cell line development are keystone technologies in the making of gene therapies 46 scientific experts based in Cologne, G...
October 06, 2022 | News
Astellas and Pantherna Enter into a New Technology Evaluation Agreement
Astellas Pharma Inc. (TSE:4503, President and CEO: Kenji Yasukawa, Ph.D., "Astellas") and Pantherna Therapeutics GmbH (CEO:Klaus Giese, Ph.D., "Panthe...
October 04, 2022 | News
Merck Enters Collaboration and Option to License Agreement with Nerviano Medical Sciences to Develop Next-Generation PARP1 Selective Inhibitor
NMS-293 is a next generation, orally available, brain-penetrant PARP1 selective inhibitor NMS-293 is currently studied in Phase I as monotherapy for the...
September 27, 2022 | News
Sciwind Biosciences and SynerK Enter into Research Partnership
The partnership combines Sciwind's expertise in disease biology and clinical development capabilities with SynerK's proprietary conjugate-based siRNA deliv...
September 27, 2022 | News
AAHRPP Accredits Five More Research Organizations, Including First in Japan
At its September meeting, AAHRPP's Council on Accreditation awarded full accreditation to: Adventist Health Glendale, Glendale, California, a hospi...
September 26, 2022 | News
SCG Cell Therapy To Establish Cell Therapy Pilot cGMP Manufacturing Facility And R&D Centre In Singapore
With the support of the Singapore Economic Development Board (EDB), the hub comprises a pilot manufacturing facility and an R&D centre. SCG expect...
September 21, 2022 | News
CellResearch Corporation (CRC) announces positive results of Phase I study for CorLiCyte®
CorLiCyte® is in development for the treatment of a number of serious conditions, with a first target indication of treating diabetic foot ulcer (...
September 19, 2022 | News
United Imaging Announces Clinical System Installations at Huntsman Cancer Institute at the University of Utah
United Imaging, a global leader in advanced medical imaging and radiotherapy equipment, announced that The Center for Quantitative Cancer Imaging ...
September 16, 2022 | News
Merck announced that the IAP (inhibitor of apoptosis protein) inhibitor xevinapant (formerly known as Debio 1143) plus chemoradiotherapy (CRT) markedly improved long-term efficacy outcomes in patients
First randomized trial in decades to show significant improvement in overall survival in patients with LA SCCHN, reinforcing the transformative potential...
September 14, 2022 | News
Indica Labs announces collaboration with The Industrial Centre for Artificial Intelligence Research in Digital Diagnostics (iCAIRD)
Indica Labs, an industry leader in quantitative digital pathology and image management solutions, and The Industrial Centre for Artificial Intelligence Res...
September 07, 2022 | News
Breast Cancer AI Company FathomX Raises SGD$ 2.24 million in Pre-series A Funding
Through this funding, the company will be able to harness the full potential of its digital AI solution to read medical images including mammograms. The fu...
September 02, 2022 | News
EpiEndo Commences LPS Challenge Trial for Lead Candidate EP395
EpiEndo Pharmaceuticals (‘EpiEndo’), the clinical-stage biopharmaceutical company developing disease-modifying therapeutics for chro...
September 01, 2022 | News
Sanyou ,KangaBio to accelerate antibody drug development and innovation
KangaBio, as a rising star biotechnology company, is committed to developing innovative prodrugs and providing innovative medicine to address unmet clinica...
August 29, 2022 | News
Most Read
- 25 Biopharma Leaders Shaping a Sustainable 2025: Innovation Meets Environmental Responsibility
- 25 Leading AI Companies to Watch in 2025: Transforming Drug Discovery and Precision Medicine
- Mr. Brendan O’Callaghan Discusses Sanofi’s Singapore Modulus Facility: Advancing Biopharma Manufacturing and Pandemic Preparedness
- Shaping the Future of PCV Care: Insights from Roche’s Stefan Scheidl on the SALWEEN Trial
- Pam Cheng Outlines AstraZeneca’s Bold Vision for Singapore’s First End-to-End ADC Manufacturing Facility
- Shaping a Health Innovation Hub: Alessandro Falcone Reflects on JLABS Singapore’s Milestone Year and Future Goals
Bio Jobs
- Avance Clinical Appoints Jessica Han as Director of Asian Operations, Strengthening Commitment to the Asian Market
- Bristol Myers Squibb Employees Cycle Coast-to-Coast to Raise $1 Million for Cancer Research
- Pfizer Australia Commits $150M to Upgrade Melbourne Facility, Bolstering Global Fight Against Antimicrobial Resistance
- SMi Systems Appoints Dr. Stefan Hamill as Vice President of Strategy to Drive Commercialisation and Growth
- Thermo Fisher Scientific Appoints William Hung as Senior Director and General Manager for Taiwan
- Cytiva Appoints Industry Veteran Pierre-Alain Ruffieux as Chief Operating Officer
News
